Evidence map›Paper›PMID 32517527›Full record

SynthesisJournal of the American Heart Association2020

Prognostic Assessment of Right Ventricular Systolic Dysfunction on Post-Transcatheter Aortic Valve Replacement Short-Term Outcomes: Systematic Review and Meta-Analysis.

Salih N Grevious, Marcelo F Fernandes, Ama K Annor, Michel Ibrahim, Garly R Saint Croix, Eduardo de Marchena, Mauricio G Cohen, Carlos E Alfonso

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. TR and TAVR: Both true and unrelated?Proceedings (Baylor University. Medical Center) · 2024
    Article
  17. Review
  18. Article
  19. Impact of early changes in cardiac damage following transcatheter aortic valve implantation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Salih N GreviousCardiovascular Division Department of Medicine Boston University School of Medicine Boston MA.
Marcelo F FernandesCardiovascular Division Department of Medicine Emory University School of Medicine Atlanta GA.
Ama K AnnorDepartment of Medicine Baylor College of Medicine Houston TX.
Michel IbrahimCardiovascular Division Department of Medicine Boston University School of Medicine Boston MA.
Garly R Saint CroixDepartment of Medicine University of Miami Miller School of Medicine Miami FL.
Eduardo de MarchenaDepartment of Medicine University of Miami Miller School of Medicine Miami FL.
Mauricio G CohenDepartment of Medicine University of Miami Miller School of Medicine Miami FL.
Carlos E AlfonsoCardiovascular Division Department of Medicine Boston University School of Medicine Boston MA.
Boston University · USUniversity of Miami · USBaylor College of Medicine · USEmory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Right ventricular systolic dysfunction (RVSD) is a known risk factor for adverse outcome in surgical aortic valve replacement. Transcatheter aortic valve replacement (TAVR), on the other hand, has been shown to be either beneficial or have no effect on right ventricular systolic function. However, the prognostic significance of RVSD on TAVR has not been clearly determined. We conducted a systematic review and meta-analysis to define the impact of RVSD on outcomes in terms of 1-year mortality in patients with severe aortic stenosis undergoing TAVR. Methods and Results An extensive literature review was performed, with an aim to identify clinical studies that focused on the prognosis and short-term mortality of patients with severe symptomatic aortic stenosis who underwent TAVR. A total of 3166 patients from 8 selected studies were included. RVSD, as assessed with tricuspid annular plane systolic excursion, fractional area change or ejection fraction, was found to be a predictor of adverse procedural outcome after TAVR (hazard ratio, 1.31; 95% CI, 1.1-1.55;

Indexed as

Transcatheter Aortic Valve ReplacementVentricular Function, RightAgedAged, 80 and overAortic ValveAortic Valve StenosisFemaleHumansMaleRisk AssessmentRisk FactorsSeverity of Illness IndexSystoleTime FactorsTreatment OutcomeTricuspid Valve Insufficiencypredictorsprognosisquality of careright ventricular dysfunctiontranscatheter aortic valve implantation

Identifiers

PMID32517527
PMCPMC7429048
OpenAlexW3033615254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.